NCT05652283 2024-11-27Pamiparib Combined With Surufatinib for the Neoadjuvant Treatment of Unresectable Ovarian CancerAnhui Provincial Cancer HospitalPhase 2 Active not recruiting37 enrolled
NCT06437353 2024-11-27Surufatinib Combined With Carboplatin/Paclitaxel and Surufatinib Combined With Olaparib as First-line and Maintenance Therapy for Newly Diagnosed High-risk Ovarian CancerAnhui Provincial Cancer HospitalPhase 2 Recruiting74 enrolled